Do you have any questions? (088) 2080369 - 2345622 Pharmacy_QAAU@pharm.aun.edu.eg
God willing, the Clinical Pharmacy Department Council will hold its regular monthly meeting number (79) on Tuesday, August 2, 2022 at 10:00 AM
in the office of Prof. Dr. Dean of the College of Pharmacy
God willing, The Pharmaceutical Analytical Chemistry Department Council will hold its regular monthly meeting number (491) حفظ الترجمة
On Wednesday, August 3, 2022 , at eleven in the morning
God willing, The Medicinal Chemistry Department Council will hold its regular monthly meeting number (453) on Tuesday, August 2, 2022 at 10:00 AM
In The Department Library
Prof. Dr. / Ahmed Mohamed Abdel Mawla - Dean of the Faculty, received representatives of the Egyptian International Pharmaceutical Industries "EPICO", Dr. / Sayed Mohamed Manna - Director of Advertising in the company, and Dr. / Tarek Saadawi Hussein - Advertising supervisor in the company, where the Faculty organized a summer training for students, the pre-final year in cooperation with "EPICO" company, under the supervision of Prof. Dr. Mahmoud Al-Badri Abdel-Muttalib - Vice Dean for Community Service and Environmental Development, and Prof. Dr. Hassan Refaat Hassan
Vice-Dean for Education and Student Affairs. On Monday, 7/25/2022.
Prof. Dr. Ahmed Mohamed Abdel Mawla - Dean of the Faculty and members of the Faculty Council honored Prof. Dr. Mahmoud Al-Badri Abdel Muttalib - Vice Dean for Community Service and Environmental Development, and presented the Faculty shield and a certificate of thanks and appreciation for his generous effort and commendable giving.
This was done in the Faculty council hall on Sunday 24/7/2022
the Center for Pharmaceutical Services, Faculty of Pharmacy - Assiut University announces the development of new services for the HPTLC device
اضغط
Prof. Dr. Tarek Abdalla Morsy El-Gammal, President of the University, visited the Faculty, at the kind invitation of Prof. Dr. Ahmed Mohamed Abdel-Mawla, Dean of the Faculty, to open the developed classes and laboratories. The Dean of the Faculty and the Vice-Deans inaugurated the student computer labs, the IT services unit, the Clinical Pharmacy Department research laboratories, and the Student Research Unit. The Dean of the faculty received Prof. Dr. Tarek Abdullah El-Gammal, the president of the university, in the faculty council hall, and in the presence of the members of the faculty council and presented the Faculty shield to His Excellency and a brochure on the achievements of His Excellency Prof. Dr. / President of the University for the development of the Faculty of Pharmacy, Assiut University.
The visit took place on Thursday 7/21/2022.
.
The main objective of this project was to formulate novel decorated amphiphilic PLGA nanoparticles aiming
for the selective delivery of the novel peptide (CK-10) to the cancerous/tumor tissue. Novel modified microfluidic
techniques were used to formulate the nanoparticles. This technique was modified by using of Nano
Assemblr associated with salting out of the organic solvent using K2HPO4. This modification is associated
with higher peptide loading efficiencies, smaller size and higher uniformity. Size, zeta potential & qualitative
determination of the adsorbed targeting ligands were measured by dynamic light scattering and laser anemometry techniques using the zeta sizer. Quantitative estimation of the adsorbed targeting ligands was
done by colorimetry and spectrophotometric techniques. Qualitative and quantitative uptakes of the various
PLGA nanoparticles were examined by the fluorescence microscope and the flow cytometer while the cytotoxic
effect of the nanoparticles was measured by the colorimetric MTT assay. PLGA/poloxamer.FA, PLGA/
poloxamer.HA, and PLGA/poloxamer.Tf have breast cancer MDA. MB321 cellular uptakes 83.8, 75.43 & 69.37
% which are higher than those of the PLGA/B cyclodextrin.FA, PLGA/B cyclodextrin.HA and PLGA/B cyclodextrin. Tf 80.87, 74.47 & 64.67 %. Therefore, PLGA/poloxamer.FA and PLGA/poloxamer.HA show higher cytotoxicity than PLGA/ poloxamer.Tf with lower breast cancer MDA-MB-231 cell viabilities 30.74, 39.15 & 49.23 %, respectively. The design of novel decorated amphiphilic CK-10 loaded PLGA nanoparticles designed by the
novel modified microfluidic technique succeeds in forming innovative anticancer formulations candidates
for therapeutic use in aggressive breast cancers.
Prof. Dr. Ahmed Mohamed Abdel Mawla, Dean of the Faculty,
participated in the ceremony honoring Prof. Dr. Tarek Abdullah El Gamal,
President of the University,
in the Eight Hall of the University Administrative Building
on Wednesday 6/7/2022.
